These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3007668)
1. Reaction products from platinum(IV) amine compounds and 5'-GMP are mainly bis(5'-GMP)platinum(II) amine adducts. van der Veer JL; Peters AR; Reedijk J J Inorg Biochem; 1986 Feb; 26(2):137-42. PubMed ID: 3007668 [TBL] [Abstract][Full Text] [Related]
2. A surprisingly stable macrochelate formed from the reaction of cis dinuclear platinum antitumor compounds with reduced glutathione. Oehlsen ME; Hegmans A; Qu Y; Farrell N Inorg Chem; 2005 May; 44(9):3004-6. PubMed ID: 15847402 [TBL] [Abstract][Full Text] [Related]
3. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes. Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340 [TBL] [Abstract][Full Text] [Related]
4. Substitution and Reduction of Platinum(IV) Complexes by a Nucleotide, Guanosine 5'-Monophosphate. Choi S; Mahalingaiah S; Delaney S; Neale NR; Masood S Inorg Chem; 1999 Apr; 38(8):1800-1805. PubMed ID: 11670950 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro. Kratochwil NA; Zabel M; Range KJ; Bednarski PJ J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447 [TBL] [Abstract][Full Text] [Related]
6. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate. Bierbach U; Sabat M; Farrell N Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108 [TBL] [Abstract][Full Text] [Related]
7. cis-diamineplatinum (II) complexes containing phosphono carboxylate ligands as antitumor agents. Hollis LS; Miller AV; Amundsen AR; Schurig JE; Stern EW J Med Chem; 1990 Jan; 33(1):105-11. PubMed ID: 2296007 [TBL] [Abstract][Full Text] [Related]
8. Dependence of the reduction products of platinum(IV) prodrugs upon the configuration of the substrate, bulk of the carrier ligands, and nature of the reducing agent. Sinisi M; Intini FP; Natile G Inorg Chem; 2012 Sep; 51(18):9694-704. PubMed ID: 22921246 [TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic investigations on the time-dependent reaction of cis-Pt(NH3)2Cl2, Pt(en)Cl2 and Pt(pn)Cl2 with RNA fragments. Wenclawiak B; Kleiböhmer W; Krebs B J Chromatogr; 1984 Jul; 296():395-401. PubMed ID: 6207191 [TBL] [Abstract][Full Text] [Related]
11. Platinum(II) catalysis and radical intervention in reductions of platinum(IV) antitumor drugs by ascorbic acid. Weaver EL; Bose RN J Inorg Biochem; 2003 Jul; 95(4):231-9. PubMed ID: 12818793 [TBL] [Abstract][Full Text] [Related]
12. A Very Rare Example of a Structurally Characterized 3'-GMP Metal Complex. NMR and Synthetic Assessment of Adducts Formed by Guanine Derivatives with [Pt(L Ranasinghe K; Pakhomova S; Marzilli PA; Marzilli LG Inorg Chem; 2017 Jul; 56(14):8462-8477. PubMed ID: 28682064 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of the membrane interaction of polynuclear platinum anticancer agents. Implications for cellular uptake. Liu Q; Qu Y; Van Antwerpen R; Farrell N Biochemistry; 2006 Apr; 45(13):4248-56. PubMed ID: 16566599 [TBL] [Abstract][Full Text] [Related]
14. Multiple Condensation Reactions Involving Pt(II) /Pd(II) -OH2 , Pt-NH3 , and Cytosine-NH2 Groups: New Twists in Cisplatin-Nucleobase Chemistry. Yin-Bandur L; Sanz Miguel PJ; Rodríguez-Santiago L; Sodupe M; Berghaus M; Lippert B Chemistry; 2016 Sep; 22(38):13653-68. PubMed ID: 27516223 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, Characterization, and Interaction with Biomolecules of Platinum(II) Complexes with Shikimic Acid-Based Ligands. Peng Y; Zhang MM; Chen ZF; Hu K; Liu YC; Chen X; Liang H Bioinorg Chem Appl; 2013; 2013():565032. PubMed ID: 23533373 [TBL] [Abstract][Full Text] [Related]
16. Mono- and dinuclear platinum(II) compounds with 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine. Structure, cytotoxic activity and reaction with 5'-GMP. Łakomska I; Kooijman H; Spek AL; Shen WZ; Reedijk J Dalton Trans; 2009 Dec; (48):10736-41. PubMed ID: 20023903 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand. Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030 [TBL] [Abstract][Full Text] [Related]
18. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes. Westendorf AF; Bodtke A; Bednarski PJ Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431 [TBL] [Abstract][Full Text] [Related]
19. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques. Plooy AC; Fichtinger-Schepman AM; Schutte HH; van Dijk M; Lohman PH Carcinogenesis; 1985 Apr; 6(4):561-6. PubMed ID: 4039227 [TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of and platinum(II) migration in the reactions of tetrazolato-bridged dinuclear platinum(II) complexes with nucleotides. Uemura M; Komeda S J Inorg Biochem; 2017 Dec; 177():359-367. PubMed ID: 28893417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]